TAYLOR KENNEDY: Open Payments
NPI 1750097168 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 16 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $150 |
| Solventum Corporation | 2 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| UROGEN PHARMA, INC. | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $49 |
| Dilon Technologies, Inc. | 1 | $46 |
| Smith+Nephew, Inc. | 2 | $33 |
| AXOGEN | 1 | $30 |
| KYOWA KIRIN, INC. | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $21 |
Products named: ERLEADA, TECVAYLI, HEMOBLAST BELLOWS, ACTIV.A.C., COLLAGENASE SANTYL, PREVENA, POTELIGEO, ULTOMIRIS.
Industry payments across NY — which companies pay providers there.
